Background Herpes zoster (HZ) is a prevalent viral disease that inflicts substantial morbidity
and associated healthcare and socioeconomic burdens. Current treatments are not fully …

Background Several targeted therapies for cancer have been associated with
cardiovascular toxicity. The evidence for this association has not been synthesized …

Lenalidomide is a second-generation new immunomodulatory medication used to treat
multiple myeloma (MM). Its mechanism of action involves affecting the expression of …

This overview summarizes evidence for the efficacy and safety of bortezomib, thalidomide,
and lenalidomide in patients with multiple myeloma. We searched the Medline, Scopus, and …

МНОЖЕСТВЕННАЯ МИЕЛОМА/ПАРАПРОТЕИНЕМИЯ/ПРОТЕИНУРИЯ/
ПЛАЗМАТИЧЕСКИЕ КЛЕТКИ/ПРОТИВООПУХОЛЕВЫЙ ОТВЕТ/ХИМИОТЕРАПИЯ …

Chemotherapy-induced peripheral neuropathy (CIPN) is an unsolved and potentially life-
compromising problem for most patients receiving neurotoxic chemotherapy. It manifests …

BACKGROUND This study was conducted to determine whether any regulatory single‐
nucleotide polymorphism (SNP) in an inflammatory gene was associated with a high …

Multiple myeloma (MM) is the second most common hematological tumor in adults.
Immunomodulatory drugs (IMiDs), such as thalidomide and lenalidomide (Len), are effective …

This study aimed at comparing bortezomib, thalidomide, and lenalidomide in patients with
multiple myeloma (MM) for safety and efficacy using meta‐analysis. This meta‐analysis …

Antiproliferation and proapoptosis are two major molecular mechanisms of action of drugs
used for the treatment of multiple myeloma. Proteasome inhibitors, such as bortezomib (PS …